# Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

> **NCT01781975** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 67 (actual)

## Conditions studied

- Diabetes Mellitus, Type I
- Diabetes Mellitus, Insulin-Dependent, 1
- Type 1 Diabetes Mellitus
- Insulin-Dependent Diabetes Mellitus 1
- IDDM

## Interventions

- **DRUG:** Imatinib Mesylate
- **DRUG:** Placebo (For imatinib mesylate)

## Key facts

- **NCT ID:** NCT01781975
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2017-05
- **Final completion:** 2018-05
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2020-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01781975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01781975, "Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01781975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*